{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:43:46Z","timestamp":1791258226886,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T00:00:00Z","timestamp":1338249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00223-012-9612-7","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T01:06:42Z","timestamp":1339722402000},"page":"69-80","source":"Crossref","is-referenced-by-count":17,"title":["Downregulation of the Inflammatory Response by CORM-3 Results in Protective Effects in a Model of Postmenopausal Arthritis"],"prefix":"10.1007","volume":"91","author":[{"given":"Lidia","family":"Ib\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Maicas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Caeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Motterlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,29]]},"reference":[{"key":"9612_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","volume":"2","author":"SR Goldring","year":"2000","unstructured":"Goldring SR, Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2:33\u201337","journal-title":"Arthritis Res"},{"key":"9612_CR2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.62.7.617","volume":"62","author":"DH Forsblad","year":"2003","unstructured":"Forsblad DH, Larsen A, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H (2003) Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 62:617\u2013623","journal-title":"Ann Rheum Dis"},{"key":"9612_CR3","first-page":"1620","volume":"17","author":"S Goemaere","year":"1990","unstructured":"Goemaere S, Ackerman C, Goethals K, De Keyser F, Van der Straeten C, Verbruggen G, Mielants H, Veys EM (1990) Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 17:1620\u20131622","journal-title":"J Rheumatol"},{"key":"9612_CR4","first-page":"1456","volume":"30","author":"HF D\u2019Elia","year":"2003","unstructured":"D\u2019Elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H (2003) Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 30:1456\u20131463","journal-title":"J Rheumatol"},{"key":"9612_CR5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265\u20131271","journal-title":"N Engl J Med"},{"key":"9612_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.1780390307","volume":"39","author":"F Eggelmeijer","year":"1996","unstructured":"Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BA, Valkema R, Westedt ML, Landman JO, Pauwels EK, Breedveld FC (1996) Increased bone mass with pamidronate treatment in rheumatoid arthritis: results of a three-year randomized, double-blind trial. Arthritis Rheum 39:396\u2013402","journal-title":"Arthritis Rheum"},{"key":"9612_CR7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jbspin.2005.10.019","volume":"73","author":"V Breuil","year":"2006","unstructured":"Breuil V, Euller-Ziegler L (2006) Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine 73:349\u2013354","journal-title":"Joint Bone Spine"},{"key":"9612_CR8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","volume":"9","author":"R Motterlini","year":"2010","unstructured":"Motterlini R, Otterbein LE (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9:728\u2013743","journal-title":"Nat Rev Drug Discov"},{"key":"9612_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2174\/138161208783597362","volume":"14","author":"MJ Alcaraz","year":"2008","unstructured":"Alcaraz MJ, Guillen MI, Ferrandiz ML, Megias J, Motterlini R (2008) Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation. Curr Pharm Des 14:465\u2013472","journal-title":"Curr Pharm Des"},{"key":"9612_CR10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/ard.2007.082412","volume":"67","author":"ML Ferr\u00e1ndiz","year":"2008","unstructured":"Ferr\u00e1ndiz ML, Maicas N, Garcia-Arnandis I, Terencio MC, Motterlini R, Devesa I, Joosten LAB, van den Berg WB, Alcaraz MJ (2008) Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis. Ann Rheum Dis 67:1211\u20131217","journal-title":"Ann Rheum Dis"},{"key":"9612_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2010.02.028","volume":"634","author":"N Maicas","year":"2010","unstructured":"Maicas N, Ferrandiz ML, Devesa I, Motterlini R, Koenders MI, van den Berg WB, Alcaraz MJ (2010) The CO-releasing molecule CORM-3 protects against articular degradation in the K\/BxN serum transfer arthritis model. Eur J Pharmacol 634:184\u2013191","journal-title":"Eur J Pharmacol"},{"key":"9612_CR12","doi-asserted-by":"crossref","first-page":"R837","DOI":"10.1186\/ar1753","volume":"7","author":"C Jochems","year":"2005","unstructured":"Jochems C, Islander U, Erlandsson M, Verdrengh M, Ohlsson C, Carlsten H (2005) Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther 7:R837\u2013R843","journal-title":"Arthritis Res Ther"},{"key":"9612_CR13","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/01.RES.0000084381.86567.08","volume":"93","author":"JE Clark","year":"2003","unstructured":"Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R (2003) Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93:e2\u2013e8","journal-title":"Circ Res"},{"key":"9612_CR14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jcp.7.4.322","volume":"7","author":"PR Kind","year":"1954","unstructured":"Kind PR, King EJ (1954) Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 7:322\u2013326","journal-title":"J Clin Pathol"},{"key":"9612_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1364\/JOSAA.1.000612","volume":"1","author":"LA Feldkamp","year":"1984","unstructured":"Feldkamp LA, Davis LC, Krettek C (1984) Practical cone-beam algorithm. J Opt Soc Am A 1:612\u2013619","journal-title":"J Opt Soc Am A"},{"key":"9612_CR16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0167-8655(01)00141-6","volume":"23","author":"E Remy","year":"2002","unstructured":"Remy E, Thiel E (2002) Medial axis for chamfer distances: computing look-up tables and neighbourhoods in 2D or 3D. Pattern Recognit Lett 23:649\u2013661","journal-title":"Pattern Recognit Lett"},{"key":"9612_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S8756-3282(99)00098-8","volume":"25","author":"D Ulrich","year":"1999","unstructured":"Ulrich D, van Rietbergen B, Laib A, Ruegsegger P (1999) The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25:55\u201360","journal-title":"Bone"},{"key":"9612_CR18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.106.117218","volume":"321","author":"P Urquhart","year":"2007","unstructured":"Urquhart P, Rosignoli G, Cooper D, Motterlini R, Perretti M (2007) Carbon monoxide-releasing molecules modulate leukocyte\u2013endothelial interactions under flow. J Pharmacol Exp Ther 321:656\u2013662","journal-title":"J Pharmacol Exp Ther"},{"key":"9612_CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","volume":"41","author":"S Adami","year":"1987","unstructured":"Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V (1987) The acute-phase response after bisphosphonate administration. Calcif Tissue Int 41:326\u2013331","journal-title":"Calcif Tissue Int"},{"key":"9612_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0928-0987(98)00065-7","volume":"8","author":"N Makkonen","year":"1999","unstructured":"Makkonen N, Salminen A, Rogers MJ, Frith JC, Urtti A, Azhayeva E, Monkkonen J (1999) Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci 8:109\u2013118","journal-title":"Eur J Pharm Sci"},{"key":"9612_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1476-5381.1996.tb15972.x","volume":"119","author":"M Nakamura","year":"1996","unstructured":"Nakamura M, Ando T, Abe M, Kumagai K, Endo Y (1996) Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br J Pharmacol 119:205\u2013212","journal-title":"Br J Pharmacol"},{"key":"9612_CR22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2006.09.009","volume":"7","author":"X Deng","year":"2007","unstructured":"Deng X, Yu Z, Funayama H, Yamaguchi K, Sasano T, Sugawara S, Endo Y (2007) Histidine decarboxylase\u2013stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells. Int Immunopharmacol 7:152\u2013161","journal-title":"Int Immunopharmacol"},{"key":"9612_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00198-009-1129-1","volume":"21","author":"P D\u2019Amelio","year":"2010","unstructured":"D\u2019Amelio P, Grimaldi A, Cristofaro MA, Ravazzoli M, Molinatti PA, Pescarmona GP, Isaia GC (2010) Alendronate reduces osteoclast precursors in osteoporosis. Osteoporos Int 21:1741\u20131750","journal-title":"Osteoporos Int"},{"key":"9612_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","volume":"61","author":"C Ribbens","year":"2002","unstructured":"Ribbens C, Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, Houssiau FA, Malaise MG (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61:161\u2013166","journal-title":"Ann Rheum Dis"},{"issue":"spec no","key":"9612_CR25","first-page":"41","volume":"14","author":"Y Okada","year":"1987","unstructured":"Okada Y, Nagase H, Harris ED Jr (1987) Matrix metalloproteinases 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J Rheumatol 14(spec no):41\u201342","journal-title":"J Rheumatol"},{"key":"9612_CR26","first-page":"E98","volume":"56","author":"A Mamehara","year":"2010","unstructured":"Mamehara A, Sugimoto T, Sugiyama D, Morinobu S, Tsuji G, Kawano S, Morinobu A, Kumagai S (2010) Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci 56:E98\u2013E107","journal-title":"Kobe J Med Sci"},{"key":"9612_CR27","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3899\/jrheum.080926","volume":"36","author":"K Fujikawa","year":"2009","unstructured":"Fujikawa K, Kawakami A, Tamai M, Uetani M, Takao S, Arima K, Iwamoto N, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K (2009) High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion. J Rheumatol 36:1126\u20131129","journal-title":"J Rheumatol"},{"key":"9612_CR28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.61.6.530","volume":"61","author":"HJ Lehmann","year":"2002","unstructured":"Lehmann HJ, Mouritzen U, Christgau S, Cloos PA, Christiansen C (2002) Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products. Ann Rheum Dis 61:530\u2013533","journal-title":"Ann Rheum Dis"},{"key":"9612_CR29","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/jor.21394","volume":"29","author":"T Shirai","year":"2011","unstructured":"Shirai T, Kobayashi M, Nishitani K, Satake T, Kuroki H, Nakagawa Y, Nakamura T (2011) Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res 29:1572\u20131577","journal-title":"J Orthop Res"},{"key":"9612_CR30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.48.5.396","volume":"48","author":"SH Ralston","year":"1989","unstructured":"Ralston SH, Hacking L, Willocks L, Bruce F, Pitkeathly DA (1989) Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis. Ann Rheum Dis 48:396\u2013399","journal-title":"Ann Rheum Dis"},{"key":"9612_CR31","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.21236","volume":"52","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L (2005) Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. Arthritis Rheum 52:2708\u20132718","journal-title":"Arthritis Rheum"},{"key":"9612_CR32","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","volume":"94","author":"R Kitazawa","year":"1994","unstructured":"Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R (1994) Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397\u20132406","journal-title":"J Clin Invest"},{"key":"9612_CR33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229\u20131237","journal-title":"J Clin Invest"},{"key":"9612_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","volume":"321","author":"MS Nanes","year":"2003","unstructured":"Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1\u201315","journal-title":"Gene"},{"key":"9612_CR35","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1073\/pnas.0701971104","volume":"104","author":"S Ochi","year":"2007","unstructured":"Ochi S, Shinohara M, Sato K, Gober HJ, Koga T, Kodama T, Takai T, Miyasaka N, Takayanagi H (2007) Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc Natl Acad Sci USA 104:11394\u201311399","journal-title":"Proc Natl Acad Sci USA"},{"key":"9612_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","volume":"257","author":"RL Jilka","year":"1992","unstructured":"Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88\u201391","journal-title":"Science"},{"key":"9612_CR37","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.24781","volume":"60","author":"R Axmann","year":"2009","unstructured":"Axmann R, Bohm C, Kronke G, Zwerina J, Smolen J, Schett G (2009) Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum 60:2747\u20132756","journal-title":"Arthritis Rheum"},{"key":"9612_CR38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1476-5381.2009.00215.x","volume":"157","author":"H Song","year":"2009","unstructured":"Song H, Bergstrasser C, Rafat N, Hoger S, Schmidt M, Endres N, Goebeler M, Hillebrands JL, Brigelius-Flohe R, Banning A, Beck G, Loesel R, Yard BA (2009) The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression. Br J Pharmacol 157:769\u2013780","journal-title":"Br J Pharmacol"},{"key":"9612_CR39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-230X-10-42","volume":"10","author":"Y Wei","year":"2010","unstructured":"Wei Y, Chen P, De Bruyn M, Zhang W, Bremer E, Helfrich W (2010) Carbon monoxide\u2013releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol 10:42","journal-title":"BMC Gastroenterol"},{"key":"9612_CR40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.40","volume":"19","author":"T Martin","year":"2009","unstructured":"Martin T, Gooi JH, Sims NA (2009) Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr 19:73\u201388","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"9612_CR41","first-page":"2318","volume":"26","author":"FP Cantatore","year":"1999","unstructured":"Cantatore FP, Acquista CA, Pipitone V (1999) Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate. J Rheumatol 26:2318\u20132323","journal-title":"J Rheumatol"},{"key":"9612_CR42","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2174\/1381612033453749","volume":"9","author":"MJ Alcaraz","year":"2003","unstructured":"Alcaraz MJ, Fernandez P, Guillen MI (2003) Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 9:2541\u20132551","journal-title":"Curr Pharm Des"},{"key":"9612_CR43","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1096\/fj.05-4278fje","volume":"19","author":"J Zwerina","year":"2005","unstructured":"Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G, Schett G (2005) Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J 19:2011\u20132013","journal-title":"FASEB J"},{"key":"9612_CR44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/jcp.22008","volume":"222","author":"TH Lin","year":"2010","unstructured":"Lin TH, Tang CH, Hung SY, Liu SH, Lin YM, Fu WM, Yang RS (2010) Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. J Cell Physiol 222:757\u2013768","journal-title":"J Cell Physiol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-012-9612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9612-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:28:42Z","timestamp":1714044522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-012-9612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,29]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["9612"],"URL":"https:\/\/doi.org\/10.1007\/s00223-012-9612-7","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,29]]}}}